"pTCH"-ing it together: A basal cell nevus syndrome review

Dermatologic Surgery

Volumn 39, Issue 11, 2013, Pages 1557-1572

  Lam, Charlene ^a   Ou, Jason C ^b   Billingsley, Elizabeth M ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; BONE MORPHOGENETIC PROTEIN; CAPECITABINE; ETRETINATE; FLUOROURACIL; IMIQUIMOD; ISOTRETINOIN; PROTEIN BCL 2; PROTEIN PATCHED 1; RETINOIC ACID; SONIC HEDGEHOG PROTEIN; TAZAROTENE; TRANSFORMING GROWTH FACTOR BETA; VISMODEGIB;

ADOLESCENCE; AGEUSIA; ALEXANDRITE LASER; ALGORITHM; ALOPECIA; ARTHRALGIA; BASAL CELL NEVUS SYNDROME; BRAIN CALCIFICATION; BRAIN ISCHEMIA; BURN; CARBON DIOXIDE LASER; CARCINOGENESIS; CEREBROVASCULAR ACCIDENT; CHEMOPROPHYLAXIS; CHEMOSURGERY; CLINICAL EXAMINATION; CLINICAL FEATURE; CONSTIPATION; CONVERGENT STRABISMUS; CRANIOFACIAL MALFORMATION; CRYOSURGERY; DECREASED APPETITE; DEPRESSION; DIARRHEA; DNA SEQUENCE; DROSOPHILA MELANOGASTER; DRUG FATALITY; DRUG MEGADOSE; DYSGEUSIA; EARLY DIAGNOSIS; EDEMA; ENVIRONMENTAL FACTOR; EPIDERMOID CYST; EROSION; ERYTHEMA; EXCISION; EXOPHTHALMOS; FATIGUE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HEAD CIRCUMFERENCE; HEART INFARCTION; HORSESHOE KIDNEY; HUMAN; HYPODONTIA; HYPOGONADOTROPIC HYPOGONADISM; HYPOKALEMIA; HYPONATREMIA; HYPOPIGMENTATION; INFECTION; JAW CYST; KIDNEY MALFORMATION; LEIOMYOSARCOMA; LOW LEVEL LASER THERAPY; MACROCEPHALY; MEDICAL LITERATURE; MEDULLOBLASTOMA; MICROPHTHALMIA; MOUTH DISEASE; MUSCLE SPASM; MUTATIONAL ANALYSIS; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; OCULOCUTANEOUS ALBINISM; ODONTOGENIC KERATOCYST; OVARY CYST; PARAKERATOSIS; PATHOGENESIS; PHOTODYNAMIC THERAPY; PREVALENCE; PRIORITY JOURNAL; PROGNATHIA; PROGNOSIS; PULSED DYE LASER; QUALITY OF LIFE; RADIATION; REVIEW; RIB; SCAR FORMATION; SIDE EFFECT; SKIN IRRITATION; SKIN PRURITUS; SOMATIC MUTATION; SQUAMOUS EPITHELIUM; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION; UNSPECIFIED SIDE EFFECT; UREMIA; VOMITING; WEIGHT REDUCTION; XERODERMA PIGMENTOSUM;

ANILIDES; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; BASAL CELL NEVUS SYNDROME; COMBINED MODALITY THERAPY; FLUOROURACIL; GENES, TUMOR SUPPRESSOR; GERM-LINE MUTATION; HUMANS; LASER THERAPY; PHOTOCHEMOTHERAPY; PROGNOSIS; PYRIDINES; RECEPTORS, CELL SURFACE; SKIN NEOPLASMS;

EID: 84887216221     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/dsu.12241     Document Type: Review

References (133)

1. Vismodegib granted FDA approval for treatment of basal cell carcinoma. Oncology 2012; 26: 174.
2. FDA approves new treatment for most common type of skin cancer. In: US Food and Drug Adminstration; 2012.
3. Satinoff MI, Wells C,. Multiple basal cell naevus syndrome in ancient Egypt. Med Hist 1969; 13: 294-7.
4. Bree AF, Shah MR,. Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS). Am J Med Genet 2011; 155A: 2091-7.
5. Evans DG, Farndon PA,. Nevoid Basal Cell Carcinoma Syndrome. In:, Pagon RA, Bird TD, Dolan CR, et al., editors. GeneReviews™ [Internet]. Seattle, WA: University of Washington, Seattle; 1993-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1151/.
6. Endo M, Fujii K, Sugita K, Saito K, et al. Nationwide survey of nevoid basal cell carcinoma syndrome in Japan revealing the low frequency of basal cell carcinoma. Am J Med Genet 2012; 158A: 351-7.
7. Lo Muzio L,. Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis 2008; 3: 32.
8. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996; 85: 841-51.
9. Johnson RL, Rothman AL, Xie J, Goodrich LV, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996; 272: 1668-71.
10. Epstein EH,. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 2008; 8: 743-54.
11. Ingham PW, Placzek M,. Orchestrating ontogenesis: variations on a theme by sonic hedgehog. Nat Rev Genet 2006; 7: 841-50.
12. Fan Z, Li J, Du J, Zhang H, et al. A missense mutation in PTCH2 underlies dominantly inherited NBCCS in a Chinese family. J Med Genet 2008; 45: 303-8.
13. Pastorino L, Ghiorzo P, Nasti S, Battistuzzi L, et al. Identification of a SUFU germline mutation in a family with Gorlin syndrome. Am J Med Genet 2009; 149A: 1539-43.
14. Caro I, Low JA,. The role of the hedgehog signaling pathway in the development of basal cell carcinoma and opportunities for treatment. Clin Cancer Res 2010; 16: 3335-9.
15. de Zwaan SE, Haass NK,. Genetics of basal cell carcinoma. Aust J Dermatol 2010; 51: 81-92; quiz 93-4.
16. Knudson AG Jr,. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci 1971; 68: 820-3.
17. Kimonis VE, Goldstein AM, Pastakia B, Yang ML, et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 1997; 69: 299-308.
18. White JC,. Multiple benign cystic epitheliomas. J Cutan Genitourin Dis 1894; 12: 477-84.
19. Jarisch W,. Zur Lehre von den Hautgeschwulsten. Arch Dermatol Syphilol 1894; 18: 162-222.
20. Gorlin RJ, Goltz RW,. Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome. N Engl J Med 1960; 262: 908-12.
21. High A, Zedan W,. Basal cell nevus syndrome. Curr Opin Oncol 2005; 17: 160-6.
22. Bale SJ, Falk RT, Rogers GR,. Patching together the genetics of Gorlin syndrome. J Cutan Med Surg 1998; 3: 31-4.
23. Wicking C, Shanley S, Smyth I, Gillies S, et al. Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. Am J Hum Genet 1997; 60: 21-6.
24. Fujii K, Kohno Y, Sugita K, Nakamura M, et al. Mutations in the human homologue of Drosophila patched in Japanese nevoid basal cell carcinoma syndrome patients. Hum Mutat 2003; 21: 451-2.
25. Boutet N, Bignon YJ, Drouin-Garraud V, Sarda P, et al. Spectrum of PTCH1 mutations in French patients with Gorlin syndrome. J Invest Dermatol 2003; 121: 478-81.
26. Chidambaram A, Goldstein AM, Gailani MR, Gerrad B, et al. Mutations in the human homologue of the Drosophila patched gene in Caucasian and African-American nevoid basal cell carcinoma syndrome patients. Cancer Res 1996; 56: 4599-601.
27. Klein RD, Dykas DJ, Bale AE,. Clinical testing for the nevoid basal cell carcinoma syndrome in a DNA diagnostic laboratory. Genet Med 2005; 7: 611-19.
28. Jones EA, Sajid MI, Shenton A, Evans DG, et al. Basal cell carcinomas in gorlin syndrome: a review of 202 patients. J Skin Cancer 2011; 2011: 2173-8.
29. Evans DG, Ladusans EJ, Rimmer S, Burnell LD, et al. Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. J Med Genet 1993; 30: 460-4.
30. Pruvost-Balland C, Gorry P, Boutet N, Magnaldo T, et al. Clinical and genetic study in 22 patients with basal cell nevus syndrome. Ann Dermatol Venereol 2006; 133: 117-23.
31. Gorlin RJ,. Nevoid basal-cell carcinoma syndrome. Medicine 1987; 66: 98-113.
32. Goldstein AM, Pastakia B, DiGiovanna JJ, Poliak S, et al. Clinical findings in two African-American families with the nevoid basal cell carcinoma syndrome (NBCC). Am J Med Genet 1994; 50: 272-81.
33. Giuliani M, Di Stefano L, Zoccali G, Angelone E, et al. Gorlin syndrome associated with basal cell carcinoma of the vulva: a case report. Eur J Gynaecol Oncol 2006; 27: 519-22.
34. Wang SQ, Goldberg LH,. Multiple polypoid basal cell carcinomas on the perineum of a patient with basal cell nevus syndrome. J Am Acad Dermatol 2007; 57: S36-7.
35. Wadhera A, Fazio M, Bricca G, Stanton O,. Metastatic basal cell carcinoma: a case report and literature review. How accurate is our incidence data? Dermatol Online J 2006; 12: 7.
36. Lattes R, Kessler RW,. Metastasizing basal-cell epithelioma of the skin; report of two cases. Cancer 1951; 4: 866-78.
37. Rubin AI, Chen EH, Ratner D,. Basal-cell carcinoma. N Engl J Med 2005; 353: 2262-9.
38. Gutierrez MM, Mora RG,. Nevoid basal cell carcinoma syndrome. A review and case report of a patient with unilateral basal cell nevus syndrome. J Am Acad Dermatol 1986; 15: 1023-30.
39. North JP, McCalmont TH, LeBoit P,. Palmar pits associated with the nevoid basal cell carcinoma syndrome. J Cutan Pathol 2012; 39: 735-8.
40. Kiwilsza M, Sporniak-Tutak K,. Gorlin-Goltz syndrome-a medical condition requiring a multidisciplinary approach. Med Sci Monit 2012; 18: RA145-53.
41. Lo Muzio L, Nocini PF, Savoia A, Consolo U, et al. Nevoid basal cell carcinoma syndrome. Clinical findings in 37 Italian affected individuals. Clin Genet 1999; 55: 34-40.
42. Gorlin RJ,. Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med 2004; 6: 530-9.
43. Lo Muzio L, Nocini P, Bucci P, Pannone G, et al. Early diagnosis of nevoid basal cell carcinoma syndrome. J Am Dent Assoc 1999; 130: 669-74.
44. Schultz SM, Twickler DM, Wheeler DE, Hogan TD, et al. Ameloblastoma associated with basal cell nevus (Gorlin) syndrome: CT findings. J Comput Assist Tomogr 1987; 11: 901-4.
45. Hasegawa K, Amagasa T, Shioda S, Kayano T,. Basal cell nevus syndrome with squamous cell carcinoma of the maxilla: report of a case. J Oral Maxillofac Surg 1989; 47: 629-33.
46. Ruprecht A, Austermann KH, Umstadt H,. Cleft lip and palate, seldom seen features of the Gorlin-Goltz syndrome. Dentomaxillofac Radiol 1987; 16: 99-103.
47. Soekarman D, Fryns JP, Casaer P, Berghe H,. Increased head circumference and facial cleft as presenting signs of the nevoid basal-cell carcinoma syndrome. Genet Couns 1991; 2: 157-62.
48. Leonardi R, Caltabiano M, Lo Muzio L, Gorlin RJ, et al. Bilateral hyperplasia of the mandibular coronoid processes in patients with nevoid basal cell carcinoma syndrome: an undescribed sign. Am J Med Genet 2002; 110: 400-3.
49. Leonardi R, Sorge G, Caltabino M,. Bilateral hyperplasia of the mandibular coronoid processes associated with the nevoid basal cell carcinoma syndrome in an Italian boy. Br Dent J 2001; 190: 349-50.
50. Kimonis VE, Mehta SG, Digiovanna JJ, Bale SJ, et al. Radiological features in 82 patients with nevoid basal cell carcinoma (NBCC or Gorlin) syndrome. Genet Med 2004; 6: 495-502.
51. Bale SJ, Amos CI, Parry DM, Bale AE, et al. Relationship between head circumference and height in normal adults and in the nevoid basal cell carcinoma syndrome and neurofibromatosis type I. Am J Med Genet 1991; 40: 206-10.
52. Ratcliffe JF, Shanley S, Chenevix-Trench G,. The prevalence of cervical and thoracic congenital skeletal abnormalities in basal cell naevus syndrome; a review of cervical and chest radiographs in 80 patients with BCNS. Br J Radiol 1995; 68: 596-9.
53. Ly JQ,. Scintigraphic findings in Gorlin's syndrome. Clin Nucl Med 2002; 27: 913-14.
54. Manners RM, Morris RJ, Francis PJ, Hatchwell E, et al. Microphthalmos in association with Gorlin's syndrome. Br J Ophthalmol 1996; 80: 378.
55. Kraemer BB, Silva EG, Sneige N,. Fibrosarcoma of ovary. A new component in the nevoid basal-cell carcinoma syndrome. Am J Surg Pathol 1984; 8: 231-6.
56. Seracchioli R, Colombo FM, Bagnoli A, Trengia V, et al. Primary ovarian leiomyosarcoma as a new component in the nevoid basal cell carcinoma syndrome: a case report. Am J Obstet Gynecol 2003; 188: 1093-5.
57. Bossert T, Walther T, Vondrys D, Gummert JF, et al. Cardiac fibroma as an inherited manifestation of nevoid basal-cell carcinoma syndrome. Tex Heart Inst J 2006; 33: 88-90.
58. Hogge WA, Blank C, Roochvarg LB, Hogge JS, et al. Gorlin syndrome (naevoid basal cell carcinoma syndrome): prenatal detection in a fetus with macrocephaly and ventriculomegaly. Prenat Diagn 1994; 14: 725-7.
59. Beddis IR, Mott MG, Bullimore J,. Case report: nasopharyngeal rhabdomyosarcoma and Gorlin's naevoid basal cell carcinoma syndrome. Med Pediatr Oncol 1983; 11: 178-9.
60. Cajaiba MM, Bale AE, Alvarez-Franco M, McNamara J, et al. Rhabdomyosarcoma, Wilms tumor, and deletion of the patched gene in Gorlin syndrome. Nat Clin Pract Oncol 2006; 3: 575-80.
61. Herzberg JJ, Wiskemann A,. Die funfte Phakomatose. Basalzellnaevus mit familiarer Belastung und Medulloblastom [The fifth phakomatosis. Basal cell nevus with hereditary malformation and medulloblastoma.]. Dermatologica 1963; 126: 106-23.
62. O'Malley S, Weitman D, Olding M, Sekhar L,. Multiple neoplasms following craniospinal irradiation for medulloblastoma in a patient with nevoid basal cell carcinoma syndrome. Case report. J Neurosurg 1997; 86: 286-8.
63. Schweisguth O, Gerard-Marchant R, Lemerle J,. Naevomatose basocellulaire; association a' un rhabdomyosarcome congenital [Basal cell nevus syndrome. Association with congenital rhabdomyosarcoma]. Arch Fr Pediatr 1968; 25: 1083-93.
64. Dahl I, Angervall L, Save-Soderbergh J,. Foetal rhabdomyoma. Case report of a patient with two tumours. Acta Pathol Microbiol Scand 1976; 84: 107-12.
65. DiSanto S, Abt AB, Boal DK, Krummel TM,. Fetal rhabdomyoma and nevoid basal cell carcinoma syndrome. Pediatr Pathol 1992; 12: 441-7.
66. Hardisson D, Jimenez-Heffernan JA, Nistal M, et al. Neural variant of fetal rhabdomyoma and naevoid basal cell carcinoma syndrome. Histopathology 1996; 29: 247-52.
67. Schulz-Butulis BA, Gilson R, Farley M, Keeling JH,. Nevoid basal cell carcinoma syndrome and non-Hodgkin's lymphoma. Cutis 2000; 66: 35-8.
68. Yilmaz B, Goldberg LH, Schechter NR, Kemp BL, et al. Basal cell nevus syndrome concurrent with adenoid cystic carcinoma of salivary gland. J Am Acad Dermatol 2003; 48: S64-6.
69. Zaun H,. Basal cell nevus syndrome with unusual accompanying symptoms. Hautarzt 1981; 32: 455-8.
70. Chapas AM, Gilchrest BA,. Broad area photodynamic therapy for treatment of multiple basal cell carcinomas in a patient with nevoid basal cell carcinoma syndrome. J Drugs Dermatol 2006; 5: 3-5.
71. Oseroff AR, Blumenson LR, Wilson BD, Mang TS, et al. A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin) for treatment of basal cell carcinoma. Lasers Surg Med 2006; 38: 417-26.
72. Otley CC, Stasko T, Tope WD, Lebwohl M,. Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects. Dermatol Surg 2006; 32: 562-8.
73. Peck GL, DiGiovanna JJ, Sarnoff DS, Gross EG, et al. Treatment and prevention of basal cell carcinoma with oral isotretinoin. J Am Acad Dermatol 1988; 19: 176-85.
74. Moon TE, Levine N, Cartmel B, Bangert JL, et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomarkers Prev 1997; 6: 949-56.
75. Goldberg LH, Hsu SH, Alcalay J,. Effectiveness of isotretinoin in preventing the appearance of basal cell carcinomas in basal cell nevus syndrome. J Am Acad Dermatol 1989; 21: 144-5.
76. Sanchez-Conejo-Mir J, Camacho F,. Nevoid basal cell carcinoma syndrome: combined etretinate and surgical treatment. J Dermatol Surg Oncol 1989; 15: 868-71.
77. So PL, Lee K, Hebert J, Walker P, et al. Topical tazarotene chemoprevention reduces basal cell carcinoma number and size in Ptch1+/- mice exposed to ultraviolet or ionizing radiation. Cancer Res 2004; 64: 4385-9.
78. van der Geer S, Krekels GA, Verhaegh ME,. Treatment of the patient with nevoid basal cell carcinoma syndrome in a megasession. Dermatol Surg 2009; 35: 709-13.
79. Tsuji T, Otake N, Nishimura M,. Cryosurgery and topical fluorouracil: a treatment method for widespread basal cell epithelioma in basal cell nevus syndrome. J Dermatol 1993; 20: 507-13.
80. Bath-Hextall FJ, Perkins W, Bong J, Williams HC,. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev 2007; 1: CD003412.
81. Miller SJ, Alam M, Andersen J, Berg D, et al. Basal cell and squamous cell skin cancers. J Natl Compre Canc 2007; 5: 506-29.
82. Rowe DE, Carroll RJ, Day CL Jr,. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989; 15: 424-31.
83. Rowe DE, Carroll RJ, Day CL Jr,. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 15: 315-28.
84. Smeets NW, Kuijpers DI, Nelemans P, Ostertag JU, et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face-results of a retrospective study and review of the literature. Br J Dermatol 2004; 151: 141-7.
85. Leibovitch I, Huilgol SC, Selva D, Richards S, et al. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J Am Acad Dermatol 2005; 53: 452-7.
86. Southwick GJ, Schwartz RA,. The basal cell nevus syndrome: disasters occurring among a series of 36 patients. Cancer 1979; 44: 2294-305.
87. Mohs FE, Jones DL, Koranda FC,. Microscopically controlled surgery for carcinomas in patients with nevoid basal cell carcinoma syndrome. Arch Dermatol 1980; 116: 777-9.
88. Thissen MR, Neumann MH, Schouten LJ,. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 1999; 135: 1177-83.
89. Kimyai-Asadi A, Alam M, Goldberg LH, Peterson SR, et al. Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas. J Am Acad Dermatol 2005; 53: 464-8.
90. Schweiger ES, Kwasniak L, Tonkovic-Capin V,. A patient with neviod basal cell carcinoma syndrome treated successfully with photodynamic therapy: case report and review of the literature. J Drugs Dermatol 2010; 9: 167-8.
91. Gilchrest BA, Brightman LA, Thiele JJ, Wasserman DI,. Photodynamic therapy for patients with Basal cell nevus syndrome. Dermatol Surg 2009; 35: 1576-81.
92. Loncaster J, Swindell R, Slevin F, Sheridan L, et al. Efficacy of photodynamic therapy as a treatment for Gorlin syndrome-related basal cell carcinomas. Clin Oncol 2009; 21: 502-8.
93. Mougel F, Debarbieux S, Ronger-Savle S, Dalle S, et al. Methylaminolaevulinate photodynamic therapy in patients with multiple basal cell carcinomas in the setting of Gorlin-Goltz syndrome or after radiotherapy. Dermatology 2009; 219: 138-42.
94. Girard C, Debu A, Bessis D, Blatiere V, et al. Treatment of Gorlin syndrome (nevoid basal cell carcinoma syndrome) with methylaminolevulinate photodynamic therapy in seven patients, including two children: interest of tumescent anesthesia for pain control in children. J Eur Acad Dermatol Venereol 2012; 27: e171-75.
95. Itkin A, Gilchrest BA,. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Dermatol Surg 2004; 30: 1054-61.
96. Kuijpers DI, Smeets NW, Krekels GA, Thissen MR,. Photodynamic therapy as adjuvant treatment of extensive basal cell carcinoma treated with Mohs micrographic surgery. Dermatol Surg 2004; 30: 794-8.
97. Neves DR, Ramos DG, Magalhaes GM, Rodrigues Rda C, et al. Photodynamic therapy for treatment of multiple lesions on the scalp in nevoid basal cell carcinoma syndrome: case report. An Bras Dermatol 2010; 85: 545-8.
98. Nouri K, Chang A, Trent JT, Jimenez GP,. Ultrapulse CO2 used for the successful treatment of basal cell carcinomas found in patients with basal cell nevus syndrome. Dermatol Surg 2002; 28: 287-90.
99. Doctoroff A, Oberlender SA, Purcell SM,. Full-face carbon dioxide laser resurfacing in the management of a patient with the nevoid basal cell carcinoma syndrome. Dermatol Surg 2003; 29: 1236-40.
100. Krunic AL, Viehman GE, Madani S, Clark RE,. Microscopically controlled surgical excision combined with ultrapulse CO2 vaporization in the management of a patient with the nevoid basal cell carcinoma syndrome. J Dermatol 1998; 25: 10-12.
101. Ibrahimi OA, Sakamoto FH, Tannous Z, Anderson RR,. 755 nm alexandrite laser for the reduction of tumor burden in basal cell Nevus syndrome. Lasers Surg Med 2011; 43: 68-71.
102. Shah SM, Konnikov N, Duncan LM, Tannous ZS,. The effect of 595 nm pulsed dye laser on superficial and nodular basal cell carcinomas. Lasers Surg Med 2009; 41: 417-22.
103. Dixon AJ,. Multiple superficial basal cell carcinomata-topical imiquimod versus curette and cryotherapy. Aust Fam Physician 2005; 34: 49-52.
104. Gross K, Kircik L, Kricorian G,. 5% 5-Fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 2007; 33: 433-9; discussion 40.
105. Strange PR, Lang PG Jr,. Long-term management of basal cell nevus syndrome with topical tretinoin and 5-fluorouracil. J Am Acad Dermatol 1992; 27: 842-5.
106. Beach DF, Somer R,. Novel approach to Gorlin syndrome: a patient treated with oral capecitabine. J Clin Oncol 2011; 29: e397-401.
107. Geisse J, Caro I, Lindholm J, Golitz L, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004; 50: 722-33.
108. Sterry W, Ruzicka T, Herrera E, Takwale A, et al. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol 2002; 147: 1227-36.
109. Shumack S, Robinson J, Kossard S, Golitz L, et al. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Arch Dermatol 2002; 138: 1165-71.
110. Geisse JK, Rich P, Pandya A, Gross K, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol 2002; 47: 390-8.
111. Micali G, De Pasquale R, Caltabiano R, Impallomeni R, et al. Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report. J Dermatolog Treat 2002; 13: 123-7.
112. Ferreres JR, Macaya A, Jucgla A, Muniesa C, et al. Hundreds of basal cell carcinomas in a Gorlin-Goltz syndrome patient cured with imiquimod 5% cream. J Eur Acad Dermatol Venereol 2006; 20: 877-8.
113. Stockfleth E, Ulrich C, Hauschild A, Lischner S, et al. Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod. Eur J Dermatol 2002; 12: 569-72.
114. Kagy MK, Amonette R,. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient. Dermatol Surg 2000; 26: 577-8; discussion 78-9.
115. Micali G, Lacarrubba F, Nasca MR, De Pasquale R,. The use of imiquimod 5% cream for the treatment of basal cell carcinoma as observed in Gorlin's syndrome. Clin Exp Dermatol 2003; 28: 19-23.
116. Thissen MR, Kuijpers DI, Krekels GA,. Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases. J Drugs Dermatol 2006; 5: 461-4.
117. Mancuso M, Pazzaglia S, Tanori M, Hahn H, et al. Basal cell carcinoma and its development: insights from radiation-induced tumors in Ptch1-deficient mice. Cancer Res 2004; 64: 934-41.
118. Choudry Q, Patel HC, Gurusinghe NT, Evans DG,. Radiation-induced brain tumours in nevoid basal cell carcinoma syndrome: implications for treatment and surveillance. Childs Nerv Syst 2007; 23: 133-6.
119. Wallin JL, Tanna N, Misra S, Puri PK, et al. Sinonasal carcinoma after irradiation for medulloblastoma in nevoid basal cell carcinoma syndrome. Am J Otolaryngol 2007; 28: 360-2.
120. Campbell RM, Mader RD, Dufresne RG,. Meningiomas after medulloblastoma irradiation treatment in a patient with basal cell nevus syndrome. J Am Acad Dermatol 2005; 53: S256-9.
121. Walter AW,. Gorlin Syndrome. emedicine 2006.
122. Lear JT,. Oral hedgehog-pathway inhibitors for basal-cell carcinoma. N Engl J Med 2012; 366: 2225-6.
123. Sekulic A, Migden MR, Oro AE, Dirix L, et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 2012; 366: 2171-9.
124. Tang JY, Mackay-Wiggan JM, Aszterbaum M, Yauch RL, et al. Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med 2012; 366: 2180-8.
125. Genetech, Inc. Erivedge [package insert]. San Francisco: Genetech, Inc, 2012.
126. Cirrone F, Harris CS,. Vismodegib and the hedgehog pathway: a new treatment for Basal cell carcinoma. Clin Ther 2012; 34: 2039-50.
127. Wolfe CM, Green WH, Cognetta AB Jr, Hatfield HK,. Basal cell carcinoma rebound after cessation of vismodegib in a nevoid basal cell carcinoma syndrome patient. Dermatol Surg 2012; 38: 1863-6.
128. Yauch RL, Dijkgraaf GJ, Alicke B, Januario T, et al. Smoothened mutation confers resistance to a hedgehog pathway inhibitor in medulloblastoma. Science 2009; 326: 572-4.
129. Amlashi SF, Riffaud L, Brassier G, Morandi X,. Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature. Cancer 2003; 98: 618-24.
130. Schofield D, West DC, Anthony DC, Marshal R, et al. Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas. Am J Pathol 1995; 146: 472-80.
131. Su CW, Lin KL, Hou JW, Jung SM, et al. Spontaneous recovery from a medulloblastoma by a female with Gorlin-Goltz syndrome. Pediatr Neurol 2003; 28: 231-4.
132. Shah M, Mavers M, Bree A, Fosko S, et al. Quality of life and depression assessment in nevoid basal cell carcinoma syndrome. Int J Dermatol 2011; 50: 268-76.
133. Efron PA, Chen MK, Glavin FL, Kays DW, et al. Pediatric basal cell carcinoma: case reports and literature review. J Pediatr Surg 2008; 43: 2277-80.